UPDATE | February 9, 2023

What are some of the key challenges pharma has faced in 2022? Will these continue into 2023?

  • MAIL

What are some of the key challenges pharma has faced in 2022? Will these continue into 2023?

Establishing strategic partnerships with CDMOs can be a solution to the current and future challenges. This World Pharma Today roundtable discusses how CDMOs are well-positioned to progress the complex drug projects by demonstrating the technical expertise and flexibility to help address the issues pharma has faced. 

 

Read more

What are some of the key challenges pharma has faced in 2022? Will these continue into 2023?

Establishing strategic partnerships with CDMOs can be a solution to the current and future challenges. This World Pharma Today roundtable discusses how CDMOs are well-positioned to progress the complex drug projects by demonstrating the technical expertise and flexibility to help address the issues pharma has faced. 

 

Read more

  • CDO
  • CGMP
  • ADC
  • Bio Campus
  • IR
  • CMO

Share article

  • MAIL

SITE MAP

close
Close

Your download is ready

Click Download.

Close

Subscribe to Our Newsletter

Please fill in your details, select one or more areas of interest, and click the subscribe button to receive our newsletter.

Subscribe to Our Newsletter
  • Interests
  • Privacy Policy to collect the email address that I have provided until I withdraw my consent. The collected information will only be used for the purpose of mailing service. If you do not wish to consent, you will not be able to receive the newsletter. Samsung Biologics respects the privacy of its subscribers.
Close

Please fill out the form
to view the full content

Please sign up to view the post..
* Required
Privacy Policy required